Header Logo

Connection

Pankaj Singh to Mice

This is a "connection" page, showing publications Pankaj Singh has written about Mice.
Connection Strength

2.045
  1. DHODH inhibition enhances the efficacy of immune checkpoint blockade by increasing cancer cell antigen presentation. Elife. 2024 Jul 08; 12.
    View in: PubMed
    Score: 0.120
  2. The MUC1-HIF-1a signaling axis regulates pancreatic cancer pathogenesis through polyamine metabolism remodeling. Proc Natl Acad Sci U S A. 2024 Apr 02; 121(14):e2315509121.
    View in: PubMed
    Score: 0.118
  3. ENT1 blockade by CNX-774 overcomes resistance to DHODH inhibition in pancreatic cancer. Cancer Lett. 2023 01 01; 552:215981.
    View in: PubMed
    Score: 0.107
  4. JNK signaling contributes to skeletal muscle wasting and protein turnover in pancreatic cancer cachexia. Cancer Lett. 2020 10 28; 491:70-77.
    View in: PubMed
    Score: 0.092
  5. SIRT1-NOX4 signaling axis regulates cancer cachexia. J Exp Med. 2020 07 06; 217(7).
    View in: PubMed
    Score: 0.091
  6. Molecular and Physiological Evaluation of Pancreatic Cancer-Induced Cachexia. Methods Mol Biol. 2019; 1882:321-333.
    View in: PubMed
    Score: 0.082
  7. Microscale Gene Expression Analysis of Tumor-Associated Macrophages. Sci Rep. 2018 02 05; 8(1):2408.
    View in: PubMed
    Score: 0.077
  8. Hypoxia-Mediated In Vivo Tumor Glucose Uptake Measurement and Analysis. Methods Mol Biol. 2018; 1742:107-113.
    View in: PubMed
    Score: 0.077
  9. Evaluation of Macrophage Polarization in Pancreatic Cancer Microenvironment Under Hypoxia. Methods Mol Biol. 2018; 1742:265-276.
    View in: PubMed
    Score: 0.077
  10. De Novo Lipid Synthesis Facilitates Gemcitabine Resistance through Endoplasmic Reticulum Stress in Pancreatic Cancer. Cancer Res. 2017 10 15; 77(20):5503-5517.
    View in: PubMed
    Score: 0.075
  11. MUC1-Mediated Metabolic Alterations Regulate Response to Radiotherapy in Pancreatic Cancer. Clin Cancer Res. 2017 Oct 01; 23(19):5881-5891.
    View in: PubMed
    Score: 0.074
  12. Activation of serum/glucocorticoid-induced kinase 1 (SGK1) underlies increased glycogen levels, mTOR activation, and autophagy defects in Lafora disease. Mol Biol Cell. 2013 Dec; 24(24):3776-86.
    View in: PubMed
    Score: 0.057
  13. MUC1 mucin stabilizes and activates hypoxia-inducible factor 1 alpha to regulate metabolism in pancreatic cancer. Proc Natl Acad Sci U S A. 2012 Aug 21; 109(34):13787-92.
    View in: PubMed
    Score: 0.053
  14. The laforin-malin complex negatively regulates glycogen synthesis by modulating cellular glucose uptake via glucose transporters. Mol Cell Biol. 2012 Feb; 32(3):652-63.
    View in: PubMed
    Score: 0.050
  15. a-Tocopherol succinate protects mice against radiation-induced gastrointestinal injury. Radiat Res. 2012 Feb; 177(2):133-45.
    View in: PubMed
    Score: 0.050
  16. Radioprotective efficacy of tocopherol succinate is mediated through granulocyte-colony stimulating factor. Cytokine. 2011 Nov; 56(2):411-21.
    View in: PubMed
    Score: 0.049
  17. Whole body protection to lethally irradiated mice by oral administration of semipurified fraction of Podophyllum hexandrum and post irradiation treatment of Picrorhiza kurroa. Tokai J Exp Clin Med. 2008 Apr 20; 33(1):6-12.
    View in: PubMed
    Score: 0.039
  18. Platelet-derived growth factor receptor beta-mediated phosphorylation of MUC1 enhances invasiveness in pancreatic adenocarcinoma cells. Cancer Res. 2007 Jun 01; 67(11):5201-10.
    View in: PubMed
    Score: 0.037
  19. Cell surface-associated mucins in signal transduction. Trends Cell Biol. 2006 Sep; 16(9):467-76.
    View in: PubMed
    Score: 0.035
  20. Ecdysoneless Overexpression Drives Mammary Tumorigenesis through Upregulation of C-MYC and Glucose Metabolism. Mol Cancer Res. 2022 09 02; 20(9):1391-1404.
    View in: PubMed
    Score: 0.026
  21. IgE-Based Therapeutic Combination Enhances Antitumor Response in Preclinical Models of Pancreatic Cancer. Mol Cancer Ther. 2021 12; 20(12):2457-2468.
    View in: PubMed
    Score: 0.025
  22. The FDA-Approved Anthelmintic Pyrvinium Pamoate Inhibits Pancreatic Cancer Cells in Nutrient-Depleted Conditions by Targeting the Mitochondria. Mol Cancer Ther. 2021 11; 20(11):2166-2176.
    View in: PubMed
    Score: 0.025
  23. Fascin promotes lung cancer growth and metastasis by enhancing glycolysis and PFKFB3 expression. Cancer Lett. 2021 10 10; 518:230-242.
    View in: PubMed
    Score: 0.024
  24. Hypoxia-Driven Oncometabolite L-2HG Maintains Stemness-Differentiation Balance and Facilitates Immune Evasion in Pancreatic Cancer. Cancer Res. 2021 08 01; 81(15):4001-4013.
    View in: PubMed
    Score: 0.024
  25. Listeria monocytogenes upregulates mitochondrial calcium signalling to inhibit LC3-associated phagocytosis as a survival strategy. Nat Microbiol. 2021 03; 6(3):366-379.
    View in: PubMed
    Score: 0.024
  26. Local and systemic immunosuppression in pancreatic cancer: Targeting the stalwarts in tumor's arsenal. Biochim Biophys Acta Rev Cancer. 2020 08; 1874(1):188387.
    View in: PubMed
    Score: 0.023
  27. EHD1 and RUSC2 Control Basal Epidermal Growth Factor Receptor Cell Surface Expression and Recycling. Mol Cell Biol. 2020 03 16; 40(7).
    View in: PubMed
    Score: 0.022
  28. Monocyte metabolic reprogramming promotes pro-inflammatory activity and Staphylococcus aureus biofilm clearance. PLoS Pathog. 2020 03; 16(3):e1008354.
    View in: PubMed
    Score: 0.022
  29. Fascin Controls Metastatic Colonization and Mitochondrial Oxidative Phosphorylation by Remodeling Mitochondrial Actin Filaments. Cell Rep. 2019 09 10; 28(11):2824-2836.e8.
    View in: PubMed
    Score: 0.022
  30. p63 and SOX2 Dictate Glucose Reliance and Metabolic Vulnerabilities in Squamous Cell Carcinomas. Cell Rep. 2019 08 13; 28(7):1860-1878.e9.
    View in: PubMed
    Score: 0.021
  31. Pluronic block copolymers enhance the anti-myeloma activity of proteasome inhibitors. J Control Release. 2019 07 28; 306:149-164.
    View in: PubMed
    Score: 0.021
  32. Combination of ERK and autophagy inhibition as a treatment approach for pancreatic cancer. Nat Med. 2019 04; 25(4):628-640.
    View in: PubMed
    Score: 0.021
  33. Mitochondrial superoxide disrupts the metabolic and epigenetic landscape of CD4+ and CD8+ T-lymphocytes. Redox Biol. 2019 Oct; 27:101141.
    View in: PubMed
    Score: 0.021
  34. O-GlcNAc Transferase Suppresses Inflammation and Necroptosis by Targeting Receptor-Interacting Serine/Threonine-Protein Kinase 3. Immunity. 2019 03 19; 50(3):576-590.e6.
    View in: PubMed
    Score: 0.021
  35. O-GlcNAc Transferase Links Glucose Metabolism to MAVS-Mediated Antiviral Innate Immunity. Cell Host Microbe. 2018 12 12; 24(6):791-803.e6.
    View in: PubMed
    Score: 0.020
  36. RNA-Binding Protein HuR Regulates Both Mutant and Wild-Type IDH1 in IDH1-Mutated Cancer. Mol Cancer Res. 2019 02; 17(2):508-520.
    View in: PubMed
    Score: 0.020
  37. Targeting Hypoxia-Inducible Factor-1a/Pyruvate Dehydrogenase Kinase 1 Axis by Dichloroacetate Suppresses Bleomycin-induced Pulmonary Fibrosis. Am J Respir Cell Mol Biol. 2018 02; 58(2):216-231.
    View in: PubMed
    Score: 0.019
  38. Combination of mAb-AR20.5, anti-PD-L1 and PolyICLC inhibits tumor progression and prolongs survival of MUC1.Tg mice challenged with pancreatic tumors. Cancer Immunol Immunother. 2018 Mar; 67(3):445-457.
    View in: PubMed
    Score: 0.019
  39. The distinct metabolic phenotype of lung squamous cell carcinoma defines selective vulnerability to glycolytic inhibition. Nat Commun. 2017 05 26; 8:15503.
    View in: PubMed
    Score: 0.018
  40. Amino acid transporter SLC6A14 is a novel and effective drug target for pancreatic cancer. Br J Pharmacol. 2016 Dec; 173(23):3292-3306.
    View in: PubMed
    Score: 0.018
  41. EGFR-Targeted Polymeric Mixed Micelles Carrying Gemcitabine for Treating Pancreatic Cancer. Biomacromolecules. 2016 Jan 11; 17(1):301-13.
    View in: PubMed
    Score: 0.017
  42. Active YAP promotes pancreatic cancer cell motility, invasion and tumorigenesis in a mitotic phosphorylation-dependent manner through LPAR3. Oncotarget. 2015 Nov 03; 6(34):36019-31.
    View in: PubMed
    Score: 0.016
  43. Granulocyte colony-stimulating factor antibody abrogates radioprotective efficacy of gamma-tocotrienol, a promising radiation countermeasure. Cytokine. 2013 May; 62(2):278-85.
    View in: PubMed
    Score: 0.014
  44. Tubastatin, a selective histone deacetylase 6 inhibitor shows anti-inflammatory and anti-rheumatic effects. Int Immunopharmacol. 2013 May; 16(1):72-8.
    View in: PubMed
    Score: 0.014
  45. Alpha-tocopherol succinate-mobilized progenitors improve intestinal integrity after whole body irradiation. Int J Radiat Biol. 2013 May; 89(5):334-45.
    View in: PubMed
    Score: 0.014
  46. Lafora disease E3 ubiquitin ligase malin is recruited to the processing bodies and regulates the microRNA-mediated gene silencing process via the decapping enzyme Dcp1a. RNA Biol. 2012 Dec; 9(12):1440-9.
    View in: PubMed
    Score: 0.013
  47. Radioprotective properties of tocopherol succinate against ionizing radiation in mice. J Radiat Res. 2013 Mar 01; 54(2):210-20.
    View in: PubMed
    Score: 0.013
  48. Overexpression of ecdysoneless in pancreatic cancer and its role in oncogenesis by regulating glycolysis. Clin Cancer Res. 2012 Nov 15; 18(22):6188-98.
    View in: PubMed
    Score: 0.013
  49. Role of radiation-induced granulocyte colony-stimulating factor in recovery from whole body gamma-irradiation. Cytokine. 2012 Jun; 58(3):406-14.
    View in: PubMed
    Score: 0.013
  50. Graviola: a novel promising natural-derived drug that inhibits tumorigenicity and metastasis of pancreatic cancer cells in vitro and in vivo through altering cell metabolism. Cancer Lett. 2012 Oct 01; 323(1):29-40.
    View in: PubMed
    Score: 0.013
  51. a-Tocopherol succinate- and AMD3100-mobilized progenitors mitigate radiation-induced gastrointestinal injury in mice. Exp Hematol. 2012 May; 40(5):407-17.
    View in: PubMed
    Score: 0.013
  52. CBLB613: a TLR 2/6 agonist, natural lipopeptide of Mycoplasma arginini , as a novel radiation countermeasure. Radiat Res. 2012 May; 177(5):628-42.
    View in: PubMed
    Score: 0.013
  53. Mobilized progenitor cells as a bridging therapy for radiation casualties: a brief review of tocopherol succinate-based approaches. Int Immunopharmacol. 2011 Jul; 11(7):842-47.
    View in: PubMed
    Score: 0.012
  54. CRTC3 links catecholamine signalling to energy balance. Nature. 2010 Dec 16; 468(7326):933-9.
    View in: PubMed
    Score: 0.012
  55. Trans-cellular introduction of HIV-1 protein Nef induces pathogenic response in Caenorhabditis elegans. PLoS One. 2010 Dec 13; 5(12):e15312.
    View in: PubMed
    Score: 0.012
  56. The malin-laforin complex suppresses the cellular toxicity of misfolded proteins by promoting their degradation through the ubiquitin-proteasome system. Hum Mol Genet. 2009 Feb 15; 18(4):688-700.
    View in: PubMed
    Score: 0.010
  57. Sonic hedgehog promotes desmoplasia in pancreatic cancer. Clin Cancer Res. 2008 Oct 01; 14(19):5995-6004.
    View in: PubMed
    Score: 0.010
  58. RNA interference suppression of MUC1 reduces the growth rate and metastatic phenotype of human pancreatic cancer cells. Clin Cancer Res. 2006 May 15; 12(10):2976-87.
    View in: PubMed
    Score: 0.009
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.